ProQR to Present AX-0810 Phase 1 Data at AASLD Liver Meeting
ProQR Therapeutics says it will present Phase 1 data for AX-0810 at the AASLD Liver Meeting.
Related stories
Axis Real Estate Investment Trust Reports Q3 2026 Profit of 54.8 Million RGT
M impact | EQUITY | Oct 29, 2026, 09:56 AM UTC
Haitian Flavoring's Q3 net profit falls more than a tenth
Haitian Flavoring reported third-quarter revenue of 64.1 hundred-million yuan, nearly flat year over year. The headline says net profit fell by more than a tenth.
M impact | EQUITY | Oct 29, 2026, 09:56 AM UTC
Axis REIT Reports Third-Quarter 2026 Results
Axis REIT reported revenue of MYR 90,779,000 and pretax profit of MYR 54,798,000 for the quarter ended September 30, 2026. Revenue was MYR 92,767,000 and pretax profit was MYR 52,1
M impact | EQUITY | Oct 29, 2026, 09:56 AM UTC
Ningbo Zhoushan Port Q3 Net Profit Falls 17.16% Y/Y
M impact | EQUITY | Oct 29, 2026, 09:56 AM UTC
Schneider Electric Infrastructure to Expand Vacuum Interrupter Capacity
Schneider Electric Infrastructure plans to increase vacuum interrupter capacity from 250,000 to 375,000 units per annum.
M impact | EQUITY | Oct 29, 2026, 09:55 AM UTC
Acwa-EIG Joint Venture Targets $4 Billion Investment in US Power Sector
Saudi Arabia’s Acwa said its joint venture with EIG targets $4 billion in investment in the US power sector.
M impact | EQUITY | Oct 29, 2026, 09:55 AM UTC